Strategy's MSCI exit looks absorbable, but two-thirds of a week's stock raise bought back preferred

Strategy's count of 13 million tracker-held shares, as relayed by CryptoSlate, implies about $1.59bn of MSCI-linked selling on 30 November, assuming all of them sell at the 11 November close. The bigger issue is financing, as most of its latest weekly common-stock proceeds did not buy bitcoin.

Strategy used $188.3m of the $283.8m it raised from common-stock sales in the week to 8 November, or 66%, to repurchase its STRC preferred shares. Only $81.9m bought bitcoin, according to its 9 November SEC filing. The MSCI deletion at the 30 November close looks smaller than JPMorgan's $2.8bn estimate. Strategy's count of 13 million tracker-held shares, as relayed by CryptoSlate, is about $1.59bn at the 11 November close.

CTOL's view: treat the deletion as absorbable and the shift of stock proceeds toward STRC as the risk to watch.

The funding machine is already spending on its capital structure

Between 2 and 8 November, Strategy sold 2,051,348 Class A shares for $283.8m net. The filing says $188.3m funded STRC repurchases and $81.9m bought 1,036 bitcoin. On CTOL's arithmetic, the repurchases took 66.3% of the proceeds and bitcoin 28.9%, so more than twice as much went to STRC as to bitcoin.

One week is not a trend. It does show that the amount of stock Strategy sells is an incomplete measure of its bitcoin buying. The company's 10-Q puts the regular STRC dividend at 12.0% a year at 30 September. A 50 basis point rise would add about $45.3m a year. That is a disclosed sensitivity, not a forecast.

The stock-sale channel is large. 24/7 Wall St reported that the third-quarter at-the-market stock program raised $5.41bn net. Saylor said of STRC, "If it trades below 100, we don't sell them," in the same report.

Coverage reviewed reports no Strategy announcement of a bitcoin sale, and a deletion does not delist the stock. Strategy held 850,364 bitcoin at 8 November. The 10-Q shows about $5.91bn of cash, deposits and investments maturing within a year. Its 2028 convertible notes, $1.010bn in principal, carry a holder put on 15 September 2027. CTOL reads the financing risk as slower funding, not an immediate cash squeeze.

MSCI's final rule made the deletion a known event

The MSCI review list dated 11 November names STRATEGY A among US deletions. Changes take effect at the close on 30 November, and rebalanced indexes start on 1 December. The stock stays listed.

Under the final methodology, a company is ineligible if it is flagged on four or more of five ratios after failing a core screen. Existing constituents must fail in both of their two most recent annual filing periods. The 10-Q already said Strategy expected its Class A shares to be excluded in the November review.

The review also deletes Metaplanet and Yellow Cake. SharpLink is on a watchlist.

The sale is about $1.59bn if the company's count holds

Strategy says MSCI-linked funds hold about 13 million shares. It puts that at 3.1% of basic shares, an implied base near 419 million on CTOL's arithmetic, and about 60% of its 30-day average daily volume. CryptoSlate relayed the count from Strategy's submission to MSCI.

On CTOL's arithmetic, 13,000,000 shares at $122.35 is $1.59bn. Strategy's 60% ratio implies daily volume near 21.7 million shares, or about $2.65bn. The count comes from Strategy's submission to MSCI. CryptoSlate does not date it precisely, so it is not as of the effective date. Its coverage of MSCI World and ACWI funds is unconfirmed, so it is the company's estimate, not an MSCI disclosure.

JPMorgan's November 2025 estimate of about $2.8bn used MSCI's earlier digital-asset proposal, not the final screen. At $122.35 that is about 22.9 million shares, or 5.4% of the 422,354,607 Class A and Class B shares on the 10-Q cover. JPMorgan's scenario put the total at $8.8bn if other index providers followed, CoinDesk reported. Coverage reviewed shows no decision from FTSE Russell, S&P Dow Jones Indices, Nasdaq or CRSP.

Bitcoin analyst Adrian Morris, quoted by CryptoSlate, said "predictions of a destabilizing selloff overlook the liquidity available in MSTR shares," putting year-to-date average daily dollar volume at $2.91bn. Markus Thielen of 10x Research told CoinDesk the outcome "has been widely expected, so most of it is already priced in." He said funds will sell, but buyers appear at slightly lower prices.

A closing-auction squeeze is the nearer risk

Average volume does not measure closing-auction demand. A Nanyang Business School summary of a 56-market study reports volume exceeding 10 times normal on the last day before implementation. Nearly half of that surge came in the final minute, when deleted stocks returned -0.37%.

That is a base rate for index mechanics, not a Strategy forecast. When MSCI backed away from its earlier proposal on 6 January 2026, Strategy rose about 6% after hours. TD Cowen's Lance Vitanza called it a possible "stay of execution", and Benchmark's Mark Palmer a "welcome reprieve", in a contemporaneous report. Strategy closed at $122.35 on 11 November and traded between $119.06 and $120.50 after hours.

Premium near parity is the longer risk

CoinDesk put Strategy's mNAV, its market value as a multiple of net asset value, at about 1.08 on 12 November. The peak was about 3.4 in November 2024. CTOL reads a high premium as letting Strategy raise cash on terms that favor existing shareholders. Near 1.0, that advantage is thin.

Steve Lee of Neoclassic Capital told The Block. He said "the bigger risk is reversing the reflexive cycle that fueled their growth." Coin Bureau's Nic Puckrin told CryptoSlate that sustained selling could compress "the premium at which MSTR trades." He said that could raise financing risk for future bitcoin purchases.

The dated test is the 30 November close, then Strategy's first Monday 8-K after it, expected on 7 December. That filing will show whether stock sales and the share going to STRC repurchases moved from the 2 to 8 November baseline. Strategy's website mNAV reading, not the 8-K, will show whether the premium held above 1.0 times. If the STRC share stays near the baseline, the evidence favours the financing reading over the index one.